Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13684308 | 0.81 | MAPK1 (0.37) | GAAALDH1A1KDM4EMAPTPIK3CD | |
| SCHEMBL13532554 | 0.81 | SMN1; SMN2 (0.39) | ALDH1A1KDM4EMEN1MAPTKMT2A | |
| SCHEMBL12308315 | 0.81 | SMN1; SMN2 (0.39) | ALDH1A1KDM4EMEN1MAPTKMT2A | |
| SCHEMBL13684329 | 0.80 | CYP19A1 (0.33) | GAAALDH1A1KDM4EMEN1MAPT | |
| SCHEMBL17736731 | 0.80 | CYP19A1 (0.33) | GAAALDH1A1KDM4EMEN1MAPT | |
| SCHEMBL21625403 | 0.79 | CYP19A1 (0.31) | CYP19A1 | |
| SCHEMBL24303333 | 0.77 | POLB (0.42) | GAAALDH1A1MEN1MAPTKMT2A | |
| SCHEMBL12534609 | 0.74 | MEN1 (0.37) | CYP2D6CYP2C19GLACYP2C9GAA | |
| SCHEMBL12308314 | 0.74 | NPSR1 (0.46) | ALDH1A1MAPTKMT2ATDP1HPGD | |
| SCHEMBL21625400 | 0.74 | PARP1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9546169-B2 | Redox active triangular organic materials | NORTHWESTERN UNIVERSITY (US) | 2017-01-17 | — | — | US | disclosed |
| US-20160130271-A1 | REDOX ACTIVE TRIANGULAR ORGANIC MATERIALS | NORTHWESTERN UNIVERSITY | 2016-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160130271-A1 | REDOX ACTIVE TRIANGULAR ORGANIC MATERIALS | MT-ND1, NQO1, GPX4 | CYP2D6 1507/4885CYP2C19 1542/4885GLA 2283/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.